Please note that the copyright of the papers below rests with a variety of different parties. They are made available solely on the same basis that I would supply a single copy of a paper to an individual. It is up to you to ensure that your use of a paper does not infringe copyright law.
Current Medline Search for Dr. Akhlaghi's Publications (PUBMED)
PUBLISHED (in reverse chronological order)
34. Mendonza AE, Gohh RY, Akhlaghi F. Blood and
plasma pharmacokinetics of ciclosporin in diabetic kidney transplant recipients.
In Press Clinical Pharmacokinetics (accepted May 2008).
33. Chitnis S, Akhlaghi F. Development
and validation of HPLC-UV method for quantitative estimation of iodixanol
in human plasma. In press J Chromatography (accepted May 2008).
32. Pabla D, Akhlaghi
F, Ahmed A, Zia H. Development
and validation of an inductively coupled plasma mass spectrometry method
for quantification of levothyroxine in dissolution studies. Rapid
Commun Mass Spectrom 22: 993-996 (2008).
31. Falck P, Åsberg
A, Guldseth H, Bremer S, Akhlaghi F, Egge Reubsaet JL, Pfeffer
P, Hartmann A, Midtvedt K. Declining
intracellular T-lymphocyte concentration of cyclosporine a precedes acute
rejection in kidney transplant recipients, Transplantation;
85: 179-184 (2008).
30. Patel CG, Richman K, Yang D, Yan B, Gohh RY, Akhlaghi F. Effect of diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipients; Therapeutic Drug Monitoring 29: 735-742 (2007).
29. Plante T, Harris D, Savitt J, Akhlaghi F, Monti J, Jay GD. Carboxyhemoglobin monitored by bedside continuous CO-oximetry. Journal of Trauma 63:1187-90 (2007).
28. Mendonza AE, Zahir H, Gohh RY, Akhlaghi F. Tacrolimus in diabetic kidney transplant recipients: pharmacokinetics and application of a limited sampling strategy. Therapeutic Drug Monitoring 29: 391-398 (2007).
27. Shi D, Yang J, Yang D, Lecluyse EL, Black C, You L, Akhlaghi F, Yan B. Response to Comments on "anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel', Journal of Pharmacology and Experimental Therapeutics 322: 424-425 (2007).
26. Patel CG, Harmon M, Gohh RY, Akhlaghi F. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus. Therapeutic Drug Monitoring, 29: 87-95 (2007).
25. Shi D, Yang J, Yang D, Lecluyse EL, Black C, You L, Akhlaghi F, Yan B. Anti-influenza viral prodrug oseltamivir is activated by carboxylesterase HCE1 and the activation is inhibited by anti-platelet agent clopidogrel, Journal of Pharmacology and Experimental Therapeutics;319: 1477-1484 (2006).
24. Zahir H, Keogh AM, Akhlaghi F. Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipids, Therapeutic Drug Monitoring 28: 818-826 (2006).
23.
Mendonza AE, Gohh RY, Akhlaghi F. Analysis
of mycophenolic acid in saliva using liquid chromatography tandem mass
spectrometry; Therapeutic Drug Monitoring 28: 402–406
(2006).
22. Akhlaghi F, Patel CG, Zuniga XP, Halilovic J, Preis IS, Gohh RY. Pharmacokinetics of mycophenolic acid and metabolites in diabetic kidney transplant recipients; Therapeutic Drug Monitoring 28: 95-101 (2006).
21. Rosenbaum SE, Akhlaghi F. Response to the Letter to the Editor by Dr Franck Saint-Marcoux et al. regarding a publication: Rosenbaum et al; Therapeutic Drug Monitoring 28: 139 (2006).
19.
Akhlaghi F, Gonzalez ML, Trull AK. Association
between cyclosporine concentrations at two hours post dose (C-2) and clinical
outcomes in de novo lung transplant recipients; Journal of Heart
Lung Transplantation 24: 2120-2128 (2005).
17. Rosenbaum SE, Baheti G, Trull AK, Akhlaghi F. Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients; Therapeutic Drug Monitoring 27: 116-122 (2005).
15. Patel CG, Mendonza AE, Akhlaghi F, Majid O, Trull AK, Lee T, Holt DW. Determination of total mycophenolic acid and its glucoronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry; J Chromatogr B Analyt Technol Biomed Life Sci. 25;813(1-2):287-294 (2004).
13. Trull AK, Akhlaghi F, Charman SC, Endenberg S, Majid O, Cornelissen J, Steel L, Parameshwar J, Wallwork J, Large S. Immunosuppression, eotaxin and the diagnostic changes in eosinophils that precede early acute heart allograft rejection; Transplant Immunology 2:159-166 (2004).
11. Akhlaghi F, Jackson C, Sharples L, Parameshwar J, Trull AK. Risk factors for the development and progression of dyslipidemia after heart transplantation; Transplantation 73:1258-1264 (2002).
9. Akhlaghi F, Charman SC, Cornelissen J, Endenburg S, Majid O, Parameshwar J, Sharples LD, Steel LA,Trull AK, Wallwork J. Eotaxin and prednisolone concentrations regulate the mobilisation of peripheral blood eosinophils preceding heart allograft rejection; Journal of Heart and Lung Transplantation 20: 161 (2001).
8. Akhlaghi F, Holt DW, Lee T, Majid O, Trull AK. Simultaneous determination of plasma prednisolone, prednisone and cortisol by high performance liquid chromatography; Therapeutic Drug Monitoring 23: 163-168 (2001).
6. Akhlaghi F, Trull AK, Steel LA, Sharples LD, Parameshwar J, Cary N, Wallwork J, Large S. Randomised trial of blood eosinophil count monitoring as a guide to corticosteroid dosage adjustment after heart transplantation; Transplantation 5: 802-809 (2000).
4. Akhlaghi F, Brown KF, Keogh AM. Unbound cyclosporine and allograft rejection after heart transplantation; Transplantation 67: 54-9 (1999).
2. Akhlaghi F, Brown KF, Keogh A, McLachlan AJ. Effect of simvastatin on cyclosporine unbound fraction and apparent blood clearance in heart transplant recipients; British Journal of Clinical Pharmacology 44: 537-542 (1997).
* The publications in hyperlink require Adobe Acrobat Reader to be viewed; select the link for instructions on downloading the software.
Last Update: May 25th, 2008
